Christophe Mellon Email

CEO . giiant pharma

Current Roles

Employees:
5
Revenue:
$387.5k
About
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
giiant pharma Address
630 Rene-Levesque Blvd. West
Montreal, QC
CAN
giiant pharma Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.